The trademark application ONGAVIA was filed by Teva Pharmaceutical Industries Ltd., a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on September 20, 2021, and it was registered by office on December 28, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and address of the trademark registration was recorded on January 3, 2022. Change of name and address of the trademark registration was recorded on July 20, 2023.